A family-based approach reveals the function of residues in the nuclear receptor ligand-binding domain.

Literature studies, 3D structure data, and a series of sequence analysis techniques were combined to reveal important residues in the structure and function of the ligand-binding domain of nuclear hormone receptors. A structure-based multiple sequence alignment allowed for the seamless combination of data from many different studies on different receptors into one single functional model. It was recently shown that a combined analysis of sequence entropy and variability can divide residues in five classes; (1) the main function or active site, (2) support for the main function, (3) signal transduction, (4) modulator or ligand binding and (5) the rest. Mutation data extracted from the literature and intermolecular contacts observed in nuclear receptor structures were analyzed in view of this classification and showed that the main function or active site residues of the nuclear receptor ligand-binding domain are involved in cofactor recruitment. Furthermore, the sequence entropy-variability analysis identified the presence of signal transduction residues that are located between the ligand, cofactor and dimer sites, suggesting communication between these regulatory binding sites. Experimental and computational results agreed well for most residues for which mutation data and intermolecular contact data were available. This allows us to predict the role of the residues for which no functional data is available yet. This study illustrates the power of family-based approaches towards the analysis of protein function, and it points out the problems and possibilities presented by the massive amounts of data that are becoming available in the "omics era". The results shed light on the nuclear receptor family that is involved in processes ranging from cancer to infertility, and that is one of the more important targets in the pharmaceutical industry.

[1]  William Bourguet,et al.  Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-α , 1995, Nature.

[2]  D. Moras,et al.  Structural basis for isotype selectivity of the human retinoic acid nuclear receptor. , 2000, Journal of molecular biology.

[3]  H. Gronemeyer,et al.  Nuclear receptor ligand-binding domains: three-dimensional structures, molecular interactions and pharmacological implications. , 2000, Trends in pharmacological sciences.

[4]  W. Kabsch,et al.  Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation , 1989, Nature.

[5]  Joost J. J. van Durme,et al.  NRMD: Nuclear Receptor Mutation Database , 2003, Nucleic Acids Res..

[6]  H. Wolfson,et al.  Flexible protein alignment and hinge detection , 2002, Proteins.

[7]  B. Katzenellenbogen,et al.  Allosteric control of ligand selectivity between estrogen receptors alpha and beta: implications for other nuclear receptors. , 2004, Molecular cell.

[8]  R. Huber,et al.  Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. Crystal structure determination and stereochemistry of the contact region. , 1973, Journal of molecular biology.

[9]  Shmuel Pietrokovski,et al.  The Blocks database--a system for protein classification , 1996, Nucleic Acids Res..

[10]  Fred E. Cohen,et al.  Automated extraction of mutation data from the literature: application of MuteXt to G protein-coupled receptors and nuclear hormone receptors , 2004, Bioinform..

[11]  Jimin Pei,et al.  AL2CO: calculation of positional conservation in a protein sequence alignment , 2001, Bioinform..

[12]  L. Mirny,et al.  Universally conserved positions in protein folds: reading evolutionary signals about stability, folding kinetics and function. , 1999, Journal of molecular biology.

[13]  Gert Vriend,et al.  Collecting and harvesting biological data: the GPCRDB and NucleaRDB information systems , 2001, Nucleic Acids Res..

[14]  L. Pauling,et al.  Evolutionary Divergence and Convergence in Proteins , 1965 .

[15]  M. Lambert,et al.  Structural basis for autorepression of retinoid X receptor by tetramer formation and the AF-2 helix. , 2000, Genes & development.

[16]  S. Jones,et al.  Prediction of protein-protein interaction sites using patch analysis. , 1997, Journal of molecular biology.

[17]  Rama Ranganathan,et al.  Structural Determinants of Allosteric Ligand Activation in RXR Heterodimers , 2004, Cell.

[18]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[19]  T. Willson,et al.  Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ , 1998, Nature.

[20]  John A. Katzenellenbogen,et al.  Allosteric Control of Ligand Selectivity between Estrogen Receptors α and β - Implications for Other Nuclear Receptors , 2004 .

[21]  J. Gustafsson,et al.  Comparing nuclear receptors in worms, flies and humans. , 2001, Trends in pharmacological sciences.

[22]  T. Gibson,et al.  Applying motif and profile searches. , 1996, Methods in enzymology.

[23]  M L Lamb,et al.  Computational approaches to molecular recognition. , 1997, Current opinion in chemical biology.

[24]  D. Moras,et al.  Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. , 2002, Molecular cell.

[25]  P. Chambon,et al.  Crystal structure of a heterodimeric complex of RAR and RXR ligand-binding domains. , 2000, Molecular cell.

[26]  L. Mirny,et al.  Evolutionary conservation of the folding nucleus. , 2000, Journal of molecular biology.

[27]  D. Mangelsdorf,et al.  Unique requirements for retinoid-dependent transcriptional activation by the orphan receptor LXR. , 1997, Genes & development.

[28]  A B Jones,et al.  Peroxisome proliferator‐activated receptor (PPAR) modulators: Diabetes and beyond * , 2001, Medicinal research reviews.

[29]  A. Hopkins,et al.  The druggable genome , 2002, Nature Reviews Drug Discovery.

[30]  John P. Overington,et al.  From comparisons of protein sequences and structures to protein modelling and design. , 1990, Trends in biochemical sciences.

[31]  Xiaohong Liu,et al.  Structure and function of Nurr1 identifies a class of ligand-independent nuclear receptors , 2003, Nature.

[32]  G Vriend,et al.  WHAT IF: a molecular modeling and drug design program. , 1990, Journal of molecular graphics.

[33]  J. Aubin,et al.  Estrogen receptor-related receptor alpha impinges on the estrogen axis in bone: potential function in osteoporosis. , 2002, Endocrinology.

[34]  J. Lehmann,et al.  Orphan nuclear receptors: shifting endocrinology into reverse. , 1999, Science.

[35]  Maria Jesus Martin,et al.  The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003 , 2003, Nucleic Acids Res..

[36]  F. Cohen,et al.  An evolutionary trace method defines binding surfaces common to protein families. , 1996, Journal of molecular biology.

[37]  T. Willson,et al.  Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. , 2000, Molecular cell.

[38]  P. Kollman,et al.  Biomolecular simulations: recent developments in force fields, simulations of enzyme catalysis, protein-ligand, protein-protein, and protein-nucleic acid noncovalent interactions. , 2001, Annual review of biophysics and biomolecular structure.

[39]  Millard H. Lambert,et al.  Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARα , 2002, Nature.

[40]  T. Willson,et al.  Peroxisome proliferator-activated receptors: from genes to physiology. , 2001, Recent progress in hormone research.

[41]  William Hyde Wollaston,et al.  I. The Croonian Lecture , 1810, Philosophical Transactions of the Royal Society of London.

[42]  B. Honig,et al.  Classical electrostatics in biology and chemistry. , 1995, Science.

[43]  R. Evans,et al.  The phantom ligand effect: allosteric control of transcription by the retinoid X receptor. , 1997, Genes & development.

[44]  David A. Agard,et al.  The Structural Basis of Estrogen Receptor/Coactivator Recognition and the Antagonism of This Interaction by Tamoxifen , 1998, Cell.

[45]  Millard H. Lambert,et al.  Asymmetry in the PPARγ/RXRα Crystal Structure Reveals the Molecular Basis of Heterodimerization among Nuclear Receptors , 2000 .

[46]  B. Katzenellenbogen,et al.  Nuclear hormone receptors: ligand-activated regulators of transcription and diverse cell responses. , 1996, Chemistry & biology.

[47]  A G Murzin,et al.  SCOP: a structural classification of proteins database for the investigation of sequences and structures. , 1995, Journal of molecular biology.

[48]  R J Fletterick,et al.  Structure and specificity of nuclear receptor-coactivator interactions. , 1998, Genes & development.

[49]  R. Fletterick,et al.  Structural basis for ligand-independent activation of the orphan nuclear receptor LRH-1. , 2003, Molecular cell.

[50]  M. Perutz,et al.  The Croonian Lecture, 1968 - The haemoglobin molecule , 1969, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[51]  I. Kuntz,et al.  Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure. , 1988, Journal of medicinal chemistry.

[52]  William Bourguet,et al.  A canonical structure for the ligand-binding domain of nuclear receptors , 1996, Nature Structural Biology.

[53]  J M Blaney,et al.  A geometric approach to macromolecule-ligand interactions. , 1982, Journal of molecular biology.

[54]  D. Moras,et al.  LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA , 1996 .

[55]  K. Umesono,et al.  The nuclear receptor superfamily: The second decade , 1995, Cell.

[56]  C. Sander,et al.  Detection of common three‐dimensional substructures in proteins , 1991, Proteins.

[57]  M J Sternberg,et al.  Supersites within superfolds. Binding site similarity in the absence of homology. , 1998, Journal of molecular biology.

[58]  Howard M. Einspahr,et al.  Crystallographic structures of the ligand-binding domains of the androgen receptor and its T877A mutant complexed with the natural agonist dihydrotestosterone , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[59]  Phillip T. Hawkins,et al.  Crystal Structure and Functional Analysis of Ras Binding to Its Effector Phosphoinositide 3-Kinase γ , 2000, Cell.

[60]  J. Kendrew,et al.  Structure of Deoxymyoglobin : A Crystallographic Study , 1966, Nature.

[61]  R. Evans,et al.  The steroid and thyroid hormone receptor superfamily. , 1988, Science.

[62]  J. Lees,et al.  Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. , 1992, The EMBO journal.

[63]  Laerte Oliveira,et al.  Sequence analysis reveals how G protein–coupled receptors transduce the signal to the G protein , 2003, Proteins.

[64]  G. Whitfield "A highly conserved region in the hormone-binding domain of the human vitamin D receptor contains residues vital for heterodimerization with retinoid X receptor and for transcriptional activation". , 1995, Molecular endocrinology.

[65]  P. Hawkins,et al.  Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. , 2000, Cell.

[66]  F. Claessens,et al.  Interaction of the putative androgen receptor-specific coactivator ARA70/ELE1alpha with multiple steroid receptors and identification of an internally deleted ELE1beta isoform. , 1999, Molecular endocrinology.

[67]  J Deisenhofer,et al.  Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution. , 1974, Journal of molecular biology.

[68]  Laerte Oliveira,et al.  Identification of functionally conserved residues with the use of entropy–variability plots , 2003, Proteins.

[69]  M. Karplus,et al.  Functionality maps of binding sites: A multiple copy simultaneous search method , 1991, Proteins.

[70]  B. Erman,et al.  Information‐theoretical entropy as a measure of sequence variability , 1991, Proteins.

[71]  W. Kabsch,et al.  Refined crystal structure of the triphosphate conformation of H‐ras p21 at 1.35 A resolution: implications for the mechanism of GTP hydrolysis. , 1990, The EMBO journal.

[72]  M. Perutz Stereochemistry of cooperative effects in haemoglobin. , 1970, Nature.

[73]  D. Eisenberg,et al.  Three-dimensional cluster analysis identifies interfaces and functional residue clusters in proteins. , 2001, Journal of molecular biology.

[74]  D. Tindall,et al.  The role of the androgen receptor in prostate cancer. , 2002, Critical reviews in eukaryotic gene expression.

[75]  L. Moore,et al.  The Human Nuclear Xenobiotic Receptor PXR: Structural Determinants of Directed Promiscuity , 2001, Science.

[76]  T. Blundell,et al.  Evolutionary trace analysis of TGF-beta and related growth factors: implications for site-directed mutagenesis. , 2000, Protein engineering.

[77]  C. Sander,et al.  A method to predict functional residues in proteins , 1995, Nature Structural Biology.

[78]  Dino Moras,et al.  Structural adaptability in the ligand-binding pocket of the ecdysone hormone receptor , 2003, Nature.

[79]  Lan Huang,et al.  Structural basis for the interaction of Ras with RaIGDS , 1998, Nature Structural Biology.

[80]  Zbigniew Dauter,et al.  Molecular basis of agonism and antagonism in the oestrogen receptor , 1997, Nature.

[81]  W. Hendrickson,et al.  Structural transitions upon ligand binding in a cooperative dimeric hemoglobin. , 1990, Science.

[82]  V. Bryson,et al.  Evolving Genes and Proteins. , 1965, Science.

[83]  K. Kaibuchi,et al.  Small GTP-binding proteins. , 1992, International review of cytology.

[84]  K. Umesono,et al.  A Unified Nomenclature System for the Nuclear Receptor Superfamily , 1999, Cell.